Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on November 1, 2007

Arteriosclerosis, Thrombosis, and Vascular Biology. 2007
Published online before print November 1, 2007, doi: 10.1161/ATVBAHA.107.154989
A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/1/187    most recent
ATVBAHA.107.154989v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohty, D.
Right arrow Articles by Mathieu, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohty, D.
Right arrow Articles by Mathieu, P.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Submitted on March 15, 2007
Accepted on October 22, 2007

Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis

Dania Mohty ; Philippe Pibarot ; Jean-Pierre Després ; Claude Côté ; Benoit Arsenault ; Amélie Cartier ; Pierre Cosnay ; Christian Couture ; and Patrick Mathieu *

From the Laboratoire d’Études Moléculaires des Valvulopathies (LEMV) (D.M., C. Côté, P.M.), Groupe de Recherche en Valvulopathies (GRV), Laval Hospital Research Center/Quebec Heart Institute, Department of Surgery, Laval University, Quebec, Canada; the Department of Medicine (D.M., P.P.), Laval University, Quebec, Canada; the Division of Kinesiology (J.-P.D., B.A., A.C.), Department of Social and Preventive Medicine, Laval University, Québec, Canada; UMR CNRS 6542 (P.C.), Université François Rabelais, Tours, France; and the Department of Pathology (C. Couture), Laval Hospital, Quebec, Canada.

* To whom correspondence should be addressed. E-mail: patrick.mathieu{at}chg.ulaval.

Objective—In patients with severe aortic stenosis (AS), we examine the association between: (1) the content of oxidized LDL (oxLDL) in the aortic valve and the degree of inflammation and remodeling; (2) The proportion of small dense LDL particles in the plasma and the presence of oxLDL in the valve along with hemodynamic progression of valve stenosis.

Methods and Results—We have examined 102 explanted AS valves. Tissue remodeling, inflammation, and accumulation of oxLDL were determined. A complete plasma lipid profile including the measurement of the relative proportion of small low-density lipoprotein (%LDL<255Å) was obtained. Valves with higher oxLDL content had a significantly higher density of inflammatory cells, expression of tumor necrosis factor (TNF)-{alpha}, and increased tissue remodeling score. The %LDL<255Å was significantly associated with oxLDL score within the aortic valve. In a subset of 59 patients in whom stenosis progression was measured, the %LDL<255Å correlated with the annualized peak gradient (r=0.29; P=0.04).

Conclusion—Increased proportion of circulating small dense LDL particles is associated with faster progression rate of stenosis and greater accumulation of oxLDL in the aortic valve. These findings suggest that therapeutic interventions aimed at lowering the production of small dense LDL particles in patients with AS might represent a potentially interesting therapeutic avenue.


Key words: aortic stenosis • oxidized low-density lipoproteins • small size low-density lipoprotein particles




This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
Y. Bosse, A. Miqdad, D. Fournier, A. Pepin, P. Pibarot, and P. Mathieu
Refining Molecular Pathways Leading to Calcific Aortic Valve Stenosis by Studying Gene Expression Profile of Normal and Calcified Stenotic Human Aortic Valves
Circ Cardiovasc Genet, October 1, 2009; 2(5): 489 - 498.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P Mathieu, P Pibarot, and J-P Despres

Heart, June 1, 2009; 95(11): 938 - 939.
[Full Text] [PDF]


Home page
HeartHome page
K Akat, M Borggrefe, and J J Kaden
Aortic valve calcification: basic science to clinical practice
Heart, April 1, 2009; 95(8): 616 - 623.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Parolari, C. Loardi, L. Mussoni, L. Cavallotti, M. Camera, P. Biglioli, E. Tremoli, and F. Alamanni
Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention
Eur. J. Cardiothorac. Surg., March 1, 2009; 35(3): 493 - 504.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
A. M. Greve and K. Wachtell
Review: Does lowering cholesterol have an impact on the progression of aortic stenosis?
Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 277 - 286.
[Abstract] [PDF]


Home page
J. Lipid Res.Home page
S. Helske, T. Miettinen, H. Gylling, M. Mayranpaa, J. Lommi, H. Turto, K. Werkkala, M. Kupari, and P. T. Kovanen
Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves
J. Lipid Res., July 1, 2008; 49(7): 1511 - 1518.
[Abstract] [Full Text] [PDF]